21213 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen Lipids, e.g. in lipopeptides
Glycolipopeptide antibodies
#302Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
#303Modulation of NKT cell activity with antigen-loaded CD1d molecules
#304Adjuvanting Material
#305Phospholipid membrane preparation
#306METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#307Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity
#308METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS
#309Antigen Delivery Compositions And Methods Of Use
#310Immunological combination compositions and methods
#311Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies
#312THERAPEUTIC VACCINE TARGETED AGAINST P-GLYCOPROTEIN 170 FOR INHIBITING MULTIDRUG RESISTANCE IN THE TREATMENT OF CANCERS
#313Formulations which stabilize and inhibit precipitation of immunogenic compositions
#314Compositions that include hemagglutinin
#315Brucellosis DNA vaccine
#316Compositions that include hemagglutinin, methods of making and methods of use thereof
#317Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
#318Ultrafiltration for preparing outer membrane vesicles
#319Antibodies with simultaneous subsite specificities to protein and lipid epitopes
#320Immunogenic lipopeptides comprising T-helper and B-cell epitopes
#321ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF
#322Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
#323Gp120 specific antigens and uses thereof
#324Prostate specific antigens and uses thereof
#325Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
#326Allergy vaccine composition, production method thereof and use of same in allergy treatment
#327Immunological combination compositions and methods
#328Antigen delivery vectors and constructs
#329Antigen delivery compositions and methods of use
#330Malarial pre-erythrocytic stage polypeptide molecules
#331Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
#332Phospholipid membrane preparation
#333Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
#334Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
#335Immunogenic composition and method of developing a vaccine based on fusion protein
#336Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
#337Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
#338Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
#339Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
#340Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
#341Immunogenic composition and method of developing a vaccine based on factor H binding sites
#342Cationic lipid-mediated enhancement of nucleic acid immunization of cats
#343Herpes zoster mRNA vaccine, preparation method therefor, and use thereof
#344Covalently modified antigens for improved immune response and/or stability
#345Vaccine RNA-peptide against SARS-CoV-2 with endogenous exosomes as carrier